Session: Engineering Stem Cell Therapy I (2012 Annual Meeting)

Description:

Stem cell research holds enormous potential for contributing towards treatment and ultimately cure for many diseases for which adequate therapy does not exist. This session focuses on utilizing stem cell for therapeutic applications in particular through bioengineering approaches. Basic understanding of stem cell behavior as well as translational studies using embryonic stem cells, induced pluripotent cells or tissue specific stem cells is of interest to this session. Topics of interest include but are not limited to: novel methods for propagation and/ or tissue specific differentiation; novel agents or biomaterials for propagation and/ or tissue specific differentiation; systems level modeling to understand stem cell behavior; signaling pathways involved in stem cell propagation and/ or differentiation.

Sponsor:

Biomedical Applications of Chemical Engineering

Co-Sponsor(s):

Engineering Fundamentals in Life Science (15d)

Chair:

Ipsita Banerjee
Assistant Professor
University of Pittsburgh
Chemical and Petroleum Engg
1242 Benedum Hall
Pittsburgh, PA 15261
Fax Number: 412-624-9639
Email: ipb1@pitt.edu

Co-Chair:

Shyni Varghese
Assistant Professor
University Of California, San Diego
Bioengineering
9500 Gilman Drive
La Jolla, CA 92093
Fax Number: 858-534-5722
Email: svarghese@ucsd.edu

Papers:

489a

Multivalent Effectors to Control Stem Cell Differentiation
Anthony Conway, University of California, Berkeley; David V. Schaffer, University of California, Berkeley

489b

Engineered Microenvironment for Osteogenic Differentiation of Stem Cells
Ameya Phadke, University of California, San Diego; Yu-Ru Shih, University of California, San Diego; Shyni Varghese, University Of California, San Diego

489c

Variation of Oxygen in a Controlled Manner Markedly Enhances Multi-Stage Differentiation of Embryonic Stem Cells to Insulin Producing Cells
Amanda R. DiIenno, Massachusetts Institute of Technology; Jeffrey R. Millman, Massachusetts Institute of Technology; Anna Kokensparger, Massachusetts Institute of Technology; Clark K. Colton, Massachusetts Institute of Technology

489d

Mesenchymal Stem Cell Therapeutics for Protection and Repair of Injured Tissues & Vital Organs
Martin L. Yarmush, Rutgers University and Massachusetts General Hospital

489e

Endothelial Cells Mediate Maturation of Human Embryonic Stem Cell Dervied Pancreatic Progenitors Into Insulin Expressing Cells
Maria Jaramillo, University of Pittsburgh; Saik Kia Goh, University of Pittsburgh; Ipsita Banerjee, University of Pittsburgh

489f

Human Induced Pluripotent Stem Cells Differentiate Into Contractile Vascular Smooth Muscle Fate Via Mesenchymal Stem Cell Intermediates: Implication for Cardiovascular Regeneration
Vivek K. Bajpai, State University of New York at Buffalo; Stelios T. Andreadis, University at Buffalo, the State University of New York

See more of this Group/Topical: Topical 7: Biomedical Applications of Chemical Engineering

<< Previous Session | Next Session >>